Shanghai Jiao Tong University School of Medicine | China
Author Profile
Scopus
Early Academic Pursuits
Dr. Jiatong Li began her academic journey with a BA in Clinical Pharmacology at Harbin Medical University, followed by a PhD in Pharmacology under the mentorship of Prof. Bao-Feng Yang. She further honed her skills through an exchange program in Cellular Physiology at Okayama University, Japan.
Professional Endeavors
Joining Shanghai Jiao Tong University School of Medicine, Dr. Li delved into research focusing on novel antitumor therapeutics. She explored pharmacodynamics, drug actions, and underlying mechanisms, contributing significantly to the field.
Contributions and Research Focus
Dr. Li's research primarily revolves around synthesizing and applying six-membered aromatic nitrogen heterocyclic anti-tumor agents. She also investigated the suppression of hepatocellular carcinoma metastasis and cancer stem cell-like properties. Additionally, her work includes solvent-free and catalyst-free direct alkylation of alkenes.
Accolades and Recognition
Dr. Li's impactful research has earned her recognition in prestigious journals, with several publications featuring as cover stories. Her contributions have significantly advanced understanding in the field of pharmacology.
Impact and Influence
Through her research, Dr. Li has made a profound impact on the pharmacological community, shedding light on innovative therapeutic approaches and mechanisms underlying cancer progression.
Legacy and Future Contributions
Dr. Li's legacy lies in her groundbreaking research, which has paved the way for further advancements in antitumor therapeutics. Her future contributions are anticipated to continue shaping the landscape of pharmacology, with a focus on addressing critical challenges in cancer treatment.
Notable Publications
Pancreatic cancer environment: From patient-derived models to single-cell omics 2024
Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023
Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)
Solvent-free and catalyst-free direct alkylation of alkenes 2023 (1)
Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)